Tuesday Nov 26
Novogen Files Suite of Patents for Anti-Tropomyosin Drug Technology
Novogen Limited today announced the filing of a family of provisional patents in the US covering anti-tropomyosin drug technology.
Novogen Limited Launches Joint Venture Aimed at Developing Drugs to Fight Ovarian Cancer
The CanTx Board will be comprised of directors representing both Novogen and CanTx will assume responsibility for advancing Novogen's super-benzopyran drug technology into the clinic for the treatment of ovarian cancer.
SNTA, DNDN, ZGNX and NVGN added to NASDAQ Active Stock Watch List at...
Synta Pharmaceuticals Corp. is currently down from its recent 52-week high, which has prompted Equity Profile Report to add the stock to their Health-care Active Stock Watch List and Investor Poll.
Investors Alert: JPMorgan Chase & Co.
Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages.